Literature DB >> 8229111

Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge.

C Benichou1, G Danan, A Flahault.   

Abstract

Standards are lacking for validation of drug causality assessment methods. An original model is proposed using a positive rechallenge as an external standard. This model was used to validate the novel causality assessment method (RUCAM) described in the previous article (Part I; J Clin Epidemiol 1993; 46: 1323). Seventy seven reports of drug-induced acute liver injuries with positive rechallenge were collected from the medical literature and divided into 49 cases and 28 controls. The RUCAM was applied to information obtained prior to readministration. The score was significantly higher (p < 10(-4)) in cases than in controls with high levels of sensitivity, specificity and predictive values. It is concluded that (1) adverse drug reaction reports with a positive rechallenge can provide a standard for validation of causality assessment methods, (2) RUCAM applied to drug-induced liver injuries has been validated.

Entities:  

Mesh:

Year:  1993        PMID: 8229111     DOI: 10.1016/0895-4356(93)90102-7

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  151 in total

1.  Jaundice due to suspected statin hepatotoxicity: a case series.

Authors:  Ottar M Bergmann; Gudjon Kristjansson; Jon G Jonasson; Einar S Björnsson
Journal:  Dig Dis Sci       Date:  2011-11-11       Impact factor: 3.199

Review 2.  Drug-induced liver disorders: implications for drug development and regulation.

Authors:  N Kaplowitz
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

3.  Chinese green tea and acute hepatitis: a rare yet recurring theme.

Authors:  Sebastian Thomas Lugg; Darryl Braganza Menezes; Simon Gompertz
Journal:  BMJ Case Rep       Date:  2015-09-23

Review 4.  Methods for causality assessment of adverse drug reactions: a systematic review.

Authors:  Taofikat B Agbabiaka; Jelena Savović; Edzard Ernst
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

5.  Herbalife hepatotoxicity: Evaluation of cases with positive reexposure tests.

Authors:  Rolf Teschke; Christian Frenzel; Johannes Schulze; Alexander Schwarzenboeck; Axel Eickhoff
Journal:  World J Hepatol       Date:  2013-07-27

Review 6.  [Morphology of drug induced liver damage].

Authors:  H-U Kasper; U Drebber; I Hirsch; H P Dienes
Journal:  Pathologe       Date:  2006-05       Impact factor: 1.011

Review 7.  Drug-induced steatohepatitis.

Authors:  Vaishali Patel; Arun J Sanyal
Journal:  Clin Liver Dis       Date:  2013-09-04       Impact factor: 6.126

8.  Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.

Authors:  Naga Chalasani; Robert J Fontana; Herbert L Bonkovsky; Paul B Watkins; Timothy Davern; Jose Serrano; Hongqiu Yang; James Rochon
Journal:  Gastroenterology       Date:  2008-09-17       Impact factor: 22.682

Review 9.  Drug-induced liver injury in the elderly.

Authors:  Jonathan G Stine; Praveen Sateesh; James H Lewis
Journal:  Curr Gastroenterol Rep       Date:  2013-01

10.  Regional surveillance of emergency-department visits for outpatient adverse drug events.

Authors:  A Capuano; A Irpino; M Gallo; L Ferrante; M L Illiano; B Rinaldi; A Filippelli; F Rossi
Journal:  Eur J Clin Pharmacol       Date:  2009-03-18       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.